Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	27.33	-301.07	-414.31
Graham Fair Price	30.20	20.79	15.96
PEG	-29.69	-1.93	-1.49
Price/Book	-22.53	21.00	27.11
Price/Cash Flow	-24.33	422.59	558.45
Prices/Earnings	36.70	-82.68	-130.62
Price/Sales	-6.50	59.16	63.27
Price/FCF	-24.33	422.59	558.45
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.74	0.72	0.75
Operating Margin	-40.64	-0.22	-0.15
ROA	-37.43	-0.03	-0.02
ROE	-0.05	-0.06	-22.39
ROIC	-0.03	-0.04	-23.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.04	-91.70
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.57	-0.38	32.65
EPS QOQ	-0.88	-0.43	51.19
FCF QOQ	0.43	0.22	-49.60
Revenue QOQ	0.06	-0.02	-71.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	63.98	53.14	-16.95
Inventory Turnover	0.00	125397000.00	100.00
Debt/Capitalization	0.52	0.48	-8.23
Quick Ratio	4.15	4.35	4.93
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.78	17.39	17.69
Cash	27.86	28.41	2.00
Capex	-0.04	< 0.005	80.49
Free Cash Flow	0.72	0.86	20.49
Revenue	6.33	6.17	-2.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.24	4.76	12.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.98	-4.54	24.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating